Epigenetic silencing of DSC3 is a common event in human breast cancer.
about
Allele-specific gene expression patterns in primary leukemic cells reveal regulation of gene expression by CpG site methylationDesmosomes in acquired diseaseMechanistic basis of desmosome-targeted diseasesAssociation of DSC3 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosisSodium metavanadate exhibits carcinogenic tendencies in vitro in immortalized human bronchial epithelial cellsAn integrated approach for identifying wrongly labelled samples when performing classification in microarray dataSalivary proteomics in bisphosphonate-related osteonecrosis of the jaw.Regulation of Desmocollin3 Expression by Promoter Hypermethylation is Associated with Advanced Esophageal Adenocarcinomas.Monomethylarsonous acid produces irreversible events resulting in malignant transformation of a human bladder cell line following 12 weeks of low-level exposureIntegrative epigenomic and genomic analysis of malignant pheochromocytoma.Unimpaired skin carcinogenesis in Desmoglein 3 knockout mice.DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer.DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF/LEF-Myc/cyclin D1/MMP signaling pathwayLoss of desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation of Akt/β-catenin signalingThe redox basis of epigenetic modifications: from mechanisms to functional consequences.Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencingLoss of Desmocollin 3 in skin tumor development and progressionDesmocollin 3 mediates follicle stimulating hormone-induced ovarian epithelial cancer cell proliferation by activating the EGFR/Akt signaling pathway.Storage Temperature Alters the Expression of Differentiation-Related Genes in Cultured Oral KeratinocytesMammary collective cell migration involves transient loss of epithelial features and individual cell migration within the epithelium.Chemical genetic screen reveals a role for desmosomal adhesion in mammary branching morphogenesis.Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma.DNA methylation in breast and colorectal cancers.Desmosomes: a role in cancer?Epigenetic remodeling during arsenical-induced malignant transformation.Broken hearts, woolly hair, and tattered skin: when desmosomal adhesion goes awry.Plakoglobin as a regulator of desmocollin gene expression.Agglomerative epigenetic aberrations are a common event in human breast cancer.Desmosomes: new perpetrators in tumour suppressionNo evidence for desmocollin 3 to serve as a prognostic marker in primary radiotherapy of head and neck cancer.Epigenetic mechanisms of breast cancer: an update of the current knowledge.Lower DSC1 expression is related to the poor differentiation and prognosis of head and neck squamous cell carcinoma (HNSCC).150th Anniversary Series: Desmosomes and the Hallmarks of Cancer.Impact of Storage Temperature on the Expression of Cell Survival Genes in Cultured ARPE-19 Cells.Pathophysiology of the Desmo-Adhesome.Epigenetic basis of cancer health disparities: Looking beyond genetic differences.Down-regulated desmocollin-2 promotes cell aggressiveness through redistributing adherens junctions and activating beta-catenin signalling in oesophageal squamous cell carcinoma.Interdependent genotoxic mechanisms of monomethylarsonous acid: role of ROS-induced DNA damage and poly(ADP-ribose) polymerase-1 inhibition in the malignant transformation of urothelial cellsThe p53 target gene desmocollin 3 acts as a novel tumor suppressor through inhibiting EGFR/ERK pathway in human lung cancer.Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma.
P2860
Q24655104-E054FB67-D4AB-4FBC-91D0-FA0A987E2FA7Q27025901-91AC3286-9D20-4547-97D5-16DAA44B3C4CQ28295898-A69D7448-1EA0-42B5-9DCD-06F2A87288F4Q28541425-2823B475-B130-49A2-8550-AEE117AA0046Q28660277-72025B42-6269-4E59-B7D7-F188DE68AE15Q30574057-09961D82-5C4E-4511-93DC-003C8C355150Q33555823-BD002814-CF87-4077-B1D5-187EF0457FC3Q33634990-3BF5CCB7-3B60-4BDB-B0AC-F9A0D7849512Q33917979-74ACD639-648D-4F35-9B3D-7FAF216DB63FQ34029818-C88F3312-A50D-452F-A6C7-D4479A1D59BEQ34490907-CF6A9DF8-A4FA-499E-A108-BEDEE34A3A83Q34727199-673694F1-3DFF-4A0F-BF19-8768C15AB240Q34758600-A3F3B65C-1CC4-4D2B-9327-E87890E193DEQ34803102-CDC324C2-DBA4-442D-8FD8-4793199E0734Q35055739-D4ED8F6C-535A-452A-8B80-D8AD10EEA7AEQ35167227-044116FB-1BC9-4254-AAE4-CB09458D2571Q35226313-828A63F0-92B6-4E1E-841D-77087E6BCEF5Q35919116-654C4DB4-4E8E-4CC6-8F83-62C0CAFE1689Q35972819-7CCBD6C5-B38A-4C5A-B263-021285E9C17BQ36111266-4F126ED7-CC45-4382-8CF6-BC452CDBE27DQ36561948-11BA9AAC-6073-4018-8342-C8989AA54D1DQ36750966-9A2508B1-E72C-450F-9C56-E0A21A0AC57DQ36803766-0F454AE2-0241-4BCC-A069-A42B3C581C1CQ36829448-1B9BC3B1-67B5-436D-A091-7E50698603DEQ36838009-D9637017-0847-48A5-BEBB-C937FA3F7768Q36976907-31A42342-DF55-4A2B-9602-60E67A4F2F51Q37141873-3211046A-5412-4625-8146-A99FDBAA5F7AQ37187180-572FE274-A45F-43B7-BB7F-A161D7EA6D1DQ37237903-57E71EEF-A0C1-48DF-9D7E-14487B3079CBQ38258636-F9175A7A-E979-4483-9D59-57730C1F8F7DQ38296760-3C9C0D3D-A761-4290-B654-781693346CBAQ38440775-1DE559A3-FF9C-4AA3-8565-961506662337Q38541665-982D8B76-4EB0-4EC6-8533-CBE169CA3D69Q38858393-5EBD1115-8A44-4A46-9C8B-661D460D79D3Q38922797-66981518-8FF2-4029-8B09-2182BC44E630Q39096966-7EDE1BAB-981E-40EB-87A4-0EAE8E05A4C3Q39128666-3E6D823F-4A9D-44B4-B589-EB284E229282Q39251501-38B239A3-649E-4892-B1AA-D4D97FC92AB8Q39286882-42BFB777-2DAA-4F9D-9CA4-B02AF09E94C2Q39422587-EF7F622A-4358-4132-89F5-E1B26A37F9BD
P2860
Epigenetic silencing of DSC3 is a common event in human breast cancer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Epigenetic silencing of DSC3 is a common event in human breast cancer
@nl
Epigenetic silencing of DSC3 is a common event in human breast cancer.
@ast
Epigenetic silencing of DSC3 is a common event in human breast cancer.
@en
Epigenetic silencing of DSC3 is a common event in human breast cancer.
@en-gb
type
label
Epigenetic silencing of DSC3 is a common event in human breast cancer
@nl
Epigenetic silencing of DSC3 is a common event in human breast cancer.
@ast
Epigenetic silencing of DSC3 is a common event in human breast cancer.
@en
Epigenetic silencing of DSC3 is a common event in human breast cancer.
@en-gb
prefLabel
Epigenetic silencing of DSC3 is a common event in human breast cancer
@nl
Epigenetic silencing of DSC3 is a common event in human breast cancer.
@ast
Epigenetic silencing of DSC3 is a common event in human breast cancer.
@en
Epigenetic silencing of DSC3 is a common event in human breast cancer.
@en-gb
P2093
P2860
P3181
P356
P1476
Epigenetic silencing of DSC3 is a common event in human breast cancer.
@en
P2093
Anne E Cress
Bernard W Futscher
Christina J Kim
Damian J Junk
Frederick E Domann
Jeanne A Burr
José L Muñoz-Rodríguez
Marc M Oshiro
Matthew Fitzgerald
Ryan J Wozniak
P2860
P2888
P304
P3181
P356
10.1186/BCR1273
P407
P577
2005-06-16T00:00:00Z
P5875
P6179
1043738677